Interestingly, when the patients were stratified according to their mutational profile, SOX10 expression appeared to be a powerful prognostic factor of oncologic outcomes in patients with BRAF-mutated melanoma (as A375 cell line) while no prognostic value was observed for RAS, NF1, and triple-negative melanomas (S4C Fig). This evidence concerns the gene SOX10 and melanoma.